POLYMORPHISM OF THE GENE ENCODING ADIPONEKTIN (+276 G> T ADIPOQ), AND EXPRESSION OF INSULIN-RESISTANT CONDITION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS (literature review and own data)

Authors

  • Karachentsev Yu. I. SI «V. Danilevsky Institute of Endocrine Pathology Problems of AMS of Ukraine», Kharkiv, Ukraine; Kharkiv Medical Academy of Postgraduate Education https://orcid.org/0000-0003-1317-6999
  • Gorshunska M. Y. Kharkiv Medical Academy of Postgraduate Education https://orcid.org/0000-0002-4402-9441
  • Atramentova L. O. SI «V. Danilevsky Institute of Endocrine Pathology Problems of AMS of Ukraine», Kharkiv, Ukraine
  • Kravchun N. A. SI «V. Danilevsky Institute of Endocrine Pathology Problems of AMS of Ukraine», Kharkiv, Ukraine
  • Khyzhnyak O. O. SI «V. Danilevsky Institute of Endocrine Pathology Problems of AMS of Ukraine», Kharkiv, Ukraine https://orcid.org/0000-0002-4541-5248
  • Tyzhnenko T. V. SI «V. Danilevsky Institute of Endocrine Pathology Problems of AMS of Ukraine», Kharkiv, Ukraine
  • Grinchenko T. S. SI «V. Danilevsky Institute of Endocrine Pathology Problems of NAMS of Ukraine», Kharkiv, Ukrain
  • Gladkich A. I. SI «V. Danilevsky Institute of Endocrine Pathology Problems of AMS of Ukraine», Kharkiv, Ukraine
  • Leshchenko Zh. A. SI «V. Danilevsky Institute of Endocrine Pathology Problems of AMS of Ukraine», Kharkiv, Ukraine https://orcid.org/0000-0002-6141-689X
  • Opaleiko Y. A. SI «V. Danilevsky Institute of Endocrine Pathology Problems of AMS of Ukraine», Kharkiv, Ukraine
  • Pochernyayev A. K. SI «V. Danilevsky Institute of Endocrine Pathology Problems of AMS of Ukraine», Kharkiv, Ukraine
  • Romanova I. P. SI «V. Danilevsky Institute of Endocrine Pathology Problems of AMS of Ukraine», Kharkiv, Ukraine
  • Poltorak V. V. SI «V. Danilevsky Institute of Endocrine Pathology Problems of AMS of Ukraine», Kharkiv, Ukraine

DOI:

https://doi.org/10.21856/j-PEP.2011.2.11

Keywords:

Adiponectin

Abstract

Adiponectin, also known as ACRP30, GBP28 and AdipoQ, is a hormone that is exclusively secreted by adipocytes. For the last several years, he has been paying particular attention to the potential role in the genesis of diabetes. The anti-inflammatory, insulin-sensitizing properties of this hormone, its ability to modulate glucose homeostasis and the metabolism of high-density lipoproteins have been proven.

References

A novel serum protein similar to C1q, produced exclusively in adipocytes [Text] / P. E. Scherer, S. Williams, M. Fogliano [et al.] // J. Biol. Chem. — Vol. 270 (45). — P. 26746–91995.

Hu E. AdipoQ is a novel adipose-specific gene dysregulated in obesity [Text] / E. Hu, P. Liang, B. M. Spiegelman // J. Biol. Chem. — 1996. — Vol. 271 (18). — P. 10697–10703.

cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1) [Text] / K. Maeda, K. Okubo, I. Shimomura [et al.] // Biochem. Biophys. Res. Commun. — 1996. — Vol. 16; 221 (2). — P. 286–289.

Adiponectin does not bind to gelatin: a new and easy way to purify high-molecular-weight adiponectin from human plasma [Text] / Y. Nakano, A. Shoji, A. Arakawa [et al.] // J. Lipid Res. — 2010. — Vol. 51 (1). — P. 210–215.

Scherer P. E. Adipose tissue: from lipid storage compartment to endocrine organ [Text] / P. E. Scherer // Diabetes. — 2006. — Vol. 55 (6). — P. 1537–1545.

Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity [Text] / Y. Arita, S. Kihara, N. Ouchi [et al.] // Biochem. Biophys. Res. Commun. — 1999. — Vol. 257 (1). — P. 79–83.

Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients [Text] / K. Hotta, T. Funahashi, Y. Arita [et al.] // Arterioscler Thromb. Vasc. Biol. — 2000. — Vol. 20 (6). — P. 1595–1599.

Association of hypoadiponectinemia with coronary artery disease in men [Text] / M. Kumada, S. Kihara, S. Sumitsuji [et al.] // Osaka CAD Study Group. Coronary artery disease. Arterioscler. Thromb. Vasc. Biol. — 2003. — Vol. 23 (1). — P. 85–89.

Heilbronn L. K. Adipose tissue macrophages, low grade inflammation and insulin resistance in human obesity [Text] / L. K. Heilbronn, L. V. Campbell // Curr. Pharm. Des. — 2008. — Vol. 14 (12). — P. 1225–1230.

Plasma adiponectin and endogenous glucose production in humans [Text] / N. Stefan, M. Stumvoll, B. Vozarova [et al.] // Diabetes Care. — 2003. — Vol. – 26 (12). — P. 3315–3319.

Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism [Text] / O. Tschritter, A. Fritsche, C. Thamer [et al.] // Diabetes. — 2003. — Vol. 52 (2). — P. 239–243.

Adiponectin, risk of coronary heart disease and correlations with cardiovascular risk markers [Text] / D. Rothenbacher, H. Brenner, W. M¨arz, W. Koenig // Europ. Heart. J. — 2005. — Vol. 26 (16). — P. 1640–1646.

Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia [Text] / C. Weyer, T. Funahashi,S. Tanaka [et al.] // J. Clin. Endocrinol. Metabol. — 2001. — Vol. 86 (5). — P. 1930–1935.

Adiponectin and development of type 2 diabetes in the Pima Indian population [Text] / R. S. Lindsay, T. Funahashi, R. L. Hanson [et al.] // Krakoff J. Lancet. — 2002. — Vol. 6. — P. 57–58.

Spranger J. New concepts in pathogenesis and treatment of diabetic retinopathy [Text] / J. Spranger, A. F. Pfeiffer // Exp Clin Endocrinol. Diabetes. — 2001. — Vol. 109. — Suppl 2. — S438–50.

Association of hypoadiponectinemia with coronary artery disease in men [Text] / M. Kumada, S. Kihara, S. Sumitsuji [et al.] // Osaka CAD Study Group. Coronary artery disease. Arterioscler. Thromb. Vasc. Biol. — 2003. — Vol. 23 (1). — P. 85–89.

Plasma adiponectin levels and risk of myocardial infarction in men [Text] / T. Pischon, C. J. Girman, G. S. Hotamisligil [et al.] // JAMA. — 2004. — Vol. 291 (14). — P. 1730–1737.

Рiвнi адипонектину у хворих на цукровий дiабет 2 типу за зiставленням з класичними та новiтнiми чинниками атерогенезу [Текст] / М. Ю. Горшунська, Ю. I. Караченцев, Н. С. Красова [та iн.] // Ендокринологiя. — 2007. — Т. 12, № 2. — С. 252–260.

Уровень адипонектина у пациентов с абдоминальным ожирением —носителей различных генотипов гена адипонектина [Текст] / О. Д. Беляева, Е. А. Баженова, А. В. Березина [и др.] // Вестник Санкт-Петербургского университета. — 2009. — Вып. 4. — С. 36–48.

Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-activated protein kinase and Akt signaling in endothelial cells [Text] / N. Ouchi, H. Kobayashi, S. Kihara [et al.] // J. Biol. Chem. — 2004. — Vol. 279 (2). — P. 1304–1309.

Hulthe J. Low adipocyte-derived plasma protein adiponectin concentrations are associated with the metabolic syndrome and small dense lowdensity lipoprotein particles: atherosclerosis and insulin resistance study [Text] / J. Hulthe, L. M. Hult´en, B. Fagerberg //Metabolism. — 2003. — Vol. 52 (12). — P. 1612–1614.

Adiponectin as a biomarker of the metabolic syndrome [Text] / M. Ryo, T. Nakamura, S. Kihara [et al.] // Circ. J. — 2004. — Vol. 68 (11). — P. 975–981.

Relationship between exercise training-induced increase in insulin sensitivity and adiponectinemia in healthy men [Text] / T. Yatagai, Y. Nishida, S. Nagasaka [et al.] // Endocrinol. J. — 2003. — Vol. 50 (2). — P. 233–238.

Shulze M. B. Primary prevention of diabetes: what can be done and how much can be prevented? [Text] / M. B. Shulze, F. B. Hu // Ann. Rev. Public. Heath. — 2005. — Vol. 26. — P. 445–467.

Regulation of gelatin-binding protein 28 (GBP28) gene expression by C/EBP [Text] / K. Saito, T. Tobe, M. Yoda [et al.] // Biol. Pharm. Bull. — 1999. — Vol. 22 (11). — P. 1158–1162.

Genomic structure and mutations in adipose-specific gene, adiponectin [Text] / M. Takahashi, Y. Arita, K. Yamagata [et al.] // Int. J. Obes. Relat. Metabol. Disord. — 2000. — Vol. 24 (7). — P. 861–868.

Genomewide search for type 2 diabetes-susceptibility genes in French whites: evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a type 2-diabetes locus on chromosome

q21-q24. [Теxt] / N. Vionnet, E. H. Hani, S. Dupont [et al.] // Am. J. Hum. Genet. — 2000. — Vol. 67 (6). — P. 1470–1480.

Genome-wide search for type 2 diabetes in Japanese affected sib-pairs confirms susceptibility genes on 3q, 15q, and 20q and identifies two new candidate Loci on 7p and 11p [Теxt] / Y. Mori, S. Otabe, C. Dina [et al.] // Diabetes. — 2002. — Vol. 51 (4). — P. 1247–1255.

The genes influencing adiponectin levels also influence risk factors for metabolic syndrome and type 2 diabetes [Теxt] / A. G. Comuzzie, M. E. Tejero, T. Funahashi [et al.] // Hum. Biol. — 2007.– Vol. 79 (2). — P. 191–200.

A haplotype at the adiponectin locus is associated with obesity and other features of the insulin resistance syndrome [Теxt] / C. Menzaghi, T. Ercolino, R. D. Paola [et al.] // Diabetes. — 2002. — Vol. 51. — Р. 2306–2312.

Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome [Теxt] / A. H. Kissebah, G. E. Sonnenberg, J. Myklebust [et al.] // Proc. Nat. Acad. Sci. USA. — 2000. — Vol. 97. — Р. 4478–14483.

Hara K. Adiponectin: an adipokine linking adipocytes and type 2 diabetes in humans [Text] / K. Hara, T. Yamauchi, T. Kadowaki // Curr. Diab. Rep. — 2005. — Vol. 5 (2). — P. 136–140.

Association of adiponectin mutation with type 2 diabetes: a candidate gene for the insulin resistance syndrome [Теxt] / H. Kondo, I. Shimomura, Y. Matsukawa [et al.] // Diabetes. — 2002. – Vol. 51 (7). — Р. 2325–2328.

Association of the T–G polymorphism in adiponectin (exon 2) with obesity and insulin sensitivity [Теxt] / M. Stumvoll, O. Tschritter, A. Fritsche [et al.] // Diabetes. — 2002. – Vol. 51. — Р. 37–41.

Single-nucleotide polymorphism haplotypes in the both proximal promoter and exon 3 of the APM1 gene modulate adipocyte-secreted adiponectin hormone levels and contribute to the genetic risk for type 2 diabetes in French Caucasians

[Теxt] / F. Vasseur, N. Helbecque, C. Dina [et al.] // Hum. Molec. Genet. — 2002. — Vol. 11. — Р. 2607–2614.

Association of the +45T/G and +276G/T polymorphisms in the adiponectin gene with insulin resistance in nondiabetic Greek women [Теxt] / L. Melistas, C. S. Mantzoros, M. Kontogianni [et al.] // Europ. J. Endocrinol. — 2009. — Vol. 161. — P. 845–852.

Adiponectin gene ADIPOQ SNP associations with serum adiponectin in two female populations and effects of SNPs on promoter activity [Теxt] / T. Kyriakou, L. J. Collins, N. J. Spencer-Jones [et al.] // J. Hum. Genet. – 2008. – Vol. 53 (8). — P. 718–

Adiponectin genetic variability, plasma adiponectin, and cardiovascular risk in patients with type 2 diabetes [Теxt] / L. Qi, A. Doria, J. E. Manson [et al.] // Diabetes. — 2006. — Vol. 55 (5). — P. 1512–1516.

Vimaleswaran K. S. Progress in the genetics of common obesity and type 2 diabetes [Теxt] / K. S. Vimaleswaran, R. J. Loos // Expert. Rev. Mol. Med. — 2010. — Vol. 12. — P. e7.

Common adiponectin gene variants show different effects on risk of cardiovascular disease and type 2 diabetes in European subjects [Теxt] / D. R. Gable, J. Matin, R. Whittall [et al.] // Ann. Hum. Genet. — 2007. — Vol. 71 (Pt 4). — P. 453–466.

Genetic architecture of the APM1 gene and its influence on adiponectin plasma levels and parameters of the metabolic syndrome in 1,727 healthy Caucasians [Text] / I. M. Heid, S. A. Wagner, H. Gohlke [et al.] // Diabetes. — 2006. — Vol. 55,

№ 2. — P. 375–384.

Mohammadzadeh G. Associations between singlenucleotide polymorphisms of the adiponectin gene, serum adiponectin levels and increased risk of type 2 diabetes mellitus in Iranian obese individuals [Теxt] / G. Mohammadzadeh, N. Zarghami //Scand. J. Clin. Lab. Invest. — 2009. –Vol. 69 (7). — P. 764–771.

Menzaghi C. Genetic influences of adiponectin on insulin resistance, type 2 diabetes, and cardiovascular disease [Теxt] / C. Menzaghi, V. Trischitta, A. Doria // Diabetes. — 2007. — Vol. 56, № 5. — P. 1198–1209.

Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man [Теxt] / D. R. Matthews, J. P. Hoske, A. S. Rudensk [et al.] // Diabetologia. — 1985. — Vol. 28. — P. 412–419.

Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans [Text] / A. Katz, S. S. Nambi, K. Mather [et al.] // J. Clin. Endocrinol. Metabol. — 2000. — Vol. 85. — P. 2402–2410.

Walsh P. S. Chelex 100 as a medium for extraction of DNA for PCR-based typing from forensic material [Text] / P. S. Walsh, D. A. Metzger, R. Higuchi // BioTechniques. — 1991. — № 10. — P. 506–513.

Linkage of plasma adiponectin levels to 3q27 explained by assosiation with variation in the APM1 gene [Text] / T. I. Pollin, K. Tanner, J. R. O’Connell [et al.] // Diabetes. — 2005. — Vol. 54. — Р. 268–274.

Гетерозиготность по SNP +276 G > T гена адипонектина как потенциальный предиктор устойчивости к сахарному диабету 2 типа [Текст] / Ю. И. Караченцев, М. Ю. Горшунская, Л. А. Атраментова [и др.] // Актуальнi проблеми акушерства i гiнекологiї, клiнiчної iмунологiї та медичної генетики. — К.; Луганськ, 2010. — С. 195–199.

Lam Т. К. Т. Free fatty acids increase basal hepatic glucose production and induce hepatic insulin resistance at different sites / Т. К. Т. Lam, G. Van de Werue, A. Giacca // Amer. J. Physiol. Endocrinol. Metabol. — 2003. — Vol. 284, № 2. — P. E281–E290.

Variants of the adiponectin gene and type 2 diabetes in a Polish population [Text] / M. Szopa, M. Malczewska-Malec, B. Kiec-Wilk [et al.] // Acta Diabetol. — 2009. — Vol. 46, № 4. — P. 317–322.

Association of the human adiponectin gene and insulin resistance [Text] / E. Filippi, F. Sentinelli, V. Trischitta [et al.] // Europ. J. Hum. Genet. — 2004. — Vol. 12, № 3. — P. 199–205.

The influence of adiponectin gene polymorphism on the rosiglitazone response in patients with type 2 diabetes [Text] / E. S. Kang, S. Y. Park, H. J. Kim [et al.] // Diabetes Care. — 2005. — Vol. 28, № 5. — P. 1139–1144.

Allele-specific differential expression of a common adiponectin gene polymorphism related to obesity [Text] / W. S. Yang, P. L. Tsou, W. J. Lee [et al.] // J. Molec. Med. — 2003. — Vol. 81, № 7. — P. 428–434.

Single nucleotide polymorphism in prohibitin 39 untranslated region and breast-cancer susceptibility [Text] / E. R. Jupe, A. A. Badgett, B. R. Neas [et al.] // Lancet. — 2001. — Vol. 357. — P. 1588–1589.

A single point mutation at the 3’-UTR of Ran mRNA leads to profound changes in lipopolysaccharide endotoxin-mediated

responses [Text] / P. M. Wong, Q. Yuan, H. Chen [et al.] // J. Biol. Chem. — 2001. — Vol. 276. — P. 33129–33138.

A common variant in PPP1R3 associated with insulin resistance and type 2 diabetes [Text] / J. B. Xia, S. W. Sherer, P. T. Cohen [et al.] // Diabetes. — 1998. — Vol. 47. — P. 1519–1524.

Linkage of Plasma Adiponectin Levels to 3q27 Explained by Association With Variation in the APM1 Gene [Text] / Toni I. Pollin, Keith Tanner, Jeffrey R. O’Connell [et al.] // Diabetes. — 2005. — Vol. 54. — P. 268–274.

Total and high-molecular-weight adiponectin and resistin in relation to the risk for type 2 diabetes in women [Text] / C. Heidemann, Q. Sun, R. M. van Dam [et al.] // Ann. Intern. Med. — 2008. — Vol. 149 (5). — P. 307–316.

Downloads

Published

2011-06-02

How to Cite

Karachentsev, Y., Gorshunska, M., Atramentova, L. O., Kravchun, N. A., Khyzhnyak, O., Tyzhnenko, T. V., Grinchenko, T. S., Gladkich, A. I., Leshchenko, Z., Opaleiko, Y. A., Pochernyayev, A. K., Romanova, I. P., & Poltorak, V. V. (2011). POLYMORPHISM OF THE GENE ENCODING ADIPONEKTIN (+276 G> T ADIPOQ), AND EXPRESSION OF INSULIN-RESISTANT CONDITION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS (literature review and own data). Problems of Endocrine Pathology, 36(2), 68-78. https://doi.org/10.21856/j-PEP.2011.2.11

Most read articles by the same author(s)

<< < 2 3 4 5 6 7 8 > >> 

Similar Articles

1 2 > >> 

You may also start an advanced similarity search for this article.